We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+23.2%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
–
AUM
$311M
AUM Growth
+$75M
Cap. Flow
+$46.3M
Cap. Flow %
14.89%
Top 10 Hldgs %
18.62%
Holding
1,633
New
628
Increased
240
Reduced
242
Closed
312

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$15.5M
2
SBSW icon
Sibanye-Stillwater
SBSW
+$3.75M
3
UNH icon
UnitedHealth
UNH
+$3.2M
4
FCRS.U
FutureCrest Acquisition Corp Units
FCRS.U
+$2.72M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$2.71M

Top Sells

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$5.26M
2
VOD icon
Vodafone
VOD
+$5.12M
3
ERIC icon
Ericsson
ERIC
+$4.88M
4
JNPR
Juniper Networks
JNPR
+$4.21M
5
CCIR
Cohen Circle Acquisition Corp. I Class A Ordinary Shares
CCIR
+$3.45M

Sector Composition

Rank Sector Weight
1 Technology 25.26%
2 Healthcare 12.39%
3 Financials 11.37%
4 Consumer Discretionary 7.84%
5 Industrials 6.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
S icon
551
SentinelOne
S
$8.17B
$36K 0.01%
+2,048
New +$36.7K
STZ icon
552
Constellation Brands
STZ
$23.3B
$36K 0.01%
+273
New +$43.4K
VIOG icon
553
Vanguard S&P Small-Cap 600 Growth ETF
VIOG
$1.13B
$36K 0.01%
+300
New +$35.6K
AHCO icon
554
AdaptHealth
AHCO
$760M
$35K 0.01%
+3,988
New +$36.9K
CART icon
555
Maplebear
CART
$11.6B
$35K 0.01%
972
– –
EMO
556
ClearBridge Energy Midstream Opportunity Fund
EMO
$1.06B
$35K 0.01%
800
+100
+14% +$4.71K
NVAX icon
557
Novavax
NVAX
$1.34B
$35K 0.01%
4,096
-3,925
-49% -$30.5K
UAA icon
558
Under Armour
UAA
$2.3B
$35K 0.01%
7,155
+6,905
+2,762% +$40.2K
VXX icon
559
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$142M
$35K 0.01%
1,084
+951
+715% +$37.6K
IRTC icon
560
iRhythm Holdings
IRTC
$4.06B
$34K 0.01%
+200
New +$31.8K
KVYO icon
561
Klaviyo
KVYO
$5.47B
$34K 0.01%
+1,228
New +$39.7K
LQDA icon
562
Liquidia Corp
LQDA
$6.45B
$34K 0.01%
+1,500
New +$32.5K
PLTR icon
563
PUT
Palantir
PLTR
$430B
$34K 0.01%
190
+150
+375% +$24.3K
RF icon
564
Regions Financial
RF
$27B
$34K 0.01%
1,300
– –
SPXX icon
565
Nuveen S&P 500 Dynamic Overwrite Fund
SPXX
$346M
$34K 0.01%
2,000
– –
TMDX icon
566
Transmedics
TMDX
$3.11B
$34K 0.01%
+305
New +$35.7K
XLU icon
567
State Street Utilities Select Sector SPDR ETF
XLU
$22.9B
$34K 0.01%
+800
New +$33.8K
BHVN
568
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$34K 0.01%
2,300
– –
BNED icon
569
Barnes & Noble Education
BNED
$424M
$33K 0.01%
3,325
-3,009
-48% -$28.1K
CDLX icon
570
Cardlytics
CDLX
$25.1M
$33K 0.01%
+1,367
New +$22.8K
DMRC icon
571
Digimarc Corp
DMRC
$158M
$33K 0.01%
3,412
+739
+28% +$7.97K
GEO icon
572
The GEO Group
GEO
$4B
$33K 0.01%
1,638
-1,163
-42% -$26.6K
JBLU icon
573
JetBlue
JBLU
$2.19B
$33K 0.01%
+6,816
New +$32.7K
PM icon
574
Philip Morris
PM
$294B
$33K 0.01%
+205
New +$34.5K
SLNO
575
DELISTED
Soleno Therapeutics
SLNO
$33K 0.01%
+500
New +$37.1K
21 22
23
24 25

Similar funds

ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
BCH
Berkshire Capital Holdings San Jose, California $277M AUM 190.28% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return
HCM
Hall Capital Management Barrington, Rhode Island $280M AUM 14.82% 1-Year Est. Return
EFP
Envision Financial Planning Memphis, Tennessee $276M AUM 10.87% 1-Year Est. Return

FNY Investment Advisers's Q3 2025 Portfolio in Review

As of Q3 2025, FNY Investment Advisers held 1,633 positions worth $311M, up 32% from $236M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

FNY Investment Advisers deployed $46.3M of net new capital in Q3 2025, opening 628 new positions and adding to 240 existing holdings. Its largest new stake was Verona Pharma: 148,120 shares worth $15.8M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Ramaco Resources Class A, an estimated $3.39M trimmed.

  • FNY Investment Advisers's largest Q3 2025 buy was Verona Pharma: 148,120 shares worth $15.8M.
  • FNY Investment Advisers added most to UnitedHealth in Q3 2025, an estimated $3.2M increase.
  • FNY Investment Advisers's biggest Q3 2025 reduction was Ramaco Resources Class A, cutting an estimated $3.39M.
  • FNY Investment Advisers fully exited Blueprint Medicines in Q3 2025, selling an estimated $5.26M.
  • FNY Investment Advisers's ten largest holdings make up 19% of its $311M portfolio in Q3 2025.
  • FNY Investment Advisers opened 628 new positions and closed 312 in Q3 2025.
  • FNY Investment Advisers's portfolio value rose 32% quarter-over-quarter to $311M.

Based on FNY Investment Advisers's 13F filing for Q3 2025, filed 15 Dec 2025.